SAN FRANCISCO , Aug. 7, 2025 /PRNewswire/ -- OneSkin, the pioneering skin longevity brand, powered by biotech and grounded in science, is proud to announce a $20 million Series A investment from growth equity firm Prelude Growth Partners. The investment, completed last month, reflects Prelude Growth's strong conviction in OneSkin's mission and potential, and marks a significant milestone in the brand's next chapter of growth.

Unlike traditional funding rounds, OneSkin was not actively seeking new capital at the time. Prelude Growth Partners proactively approached the brand with a desire to invest, and OneSkin leveraged the opportunity to replace an early seed stage investor with a partner who could best support them in this next stage of growth. This strategic investment underscor

See Full Page